VISICORT attracts attention at ARVO 2018, Honolulu

PI Dr Jesper Hjortdal (right) and Henrik Sejersen (left), Clinical Optometrist at the University Hospital Aarhus in Denmark presented VISICORT at the ARVO 2018 conference. The Association for Research in Vision and Ophthalmology (ARVO) meeting was held from 29 April – 3 May in Honolulu, Hawaii USA. This year’s theme was ‘Imaging in the Eye’. The VISICORT study was titled “Comparison of DMEK and DSAEK in high and low risk posterior lamellar keratoplasty”.

Jesper comments: “Our poster confirmed that on average, patients treated with DMEK obtain better visual acuity than patients treated with DSAEK, but that early re-operations are much more common. An interesting finding was that DMEK grafts had higher endothelial cell density after surgery than DSAEK grafts. In relation to high- and low-risk grafts, failures were similar in patients treated with DMEK/DSAEK.”
“The interest in the topic was very good, and many look very much forward to see results from the main focus of VISICORT: Immunological profiling of patients in keratoplasty.”

ARVO is the largest and most respected eye and vision research organization in the world. With nearly 12,000 researchers as members from over 75 countries, ARVO advances research worldwide into understanding the visual system and preventing, treating and curing its disorders. The poster session is very popular as many colleagues pass by and give comments.